title: From latent to patent: rethinking prediction of tuberculosis.
authors.affiliation: Amsterdam Institute for Global Health and Development and Department of Global Health, Academic Medical Center, Amsterdam, Netherlands; KNCV Tuberculosis Foundation, The Hague, Netherlands. Electronic address: f.cobelens@aighd.org.
authors.forename: Frank
authors.initials: F
authors.lastname: Cobelens
authors.affiliation: Amsterdam Institute for Global Health and Development and Department of Global Health, Academic Medical Center, Amsterdam, Netherlands; KNCV Tuberculosis Foundation, The Hague, Netherlands.
authors.forename: Sandra
authors.initials: S
authors.lastname: Kik
authors.affiliation: Radcliffe Department of Medicine, University of Oxford, United Kingdom; Clinical Infectious Diseases Research Initiative, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, South Africa.
authors.forename: Hanif
authors.initials: H
authors.lastname: Esmail
authors.affiliation: IRCCS San Raffaele Scientific Institute, Milan, Italy.
authors.forename: Daniela Maria
authors.initials: DM
authors.lastname: Cirillo
authors.affiliation: Global TB Programme, World Health Organization, Geneva, Switzerland.
authors.forename: Christian
authors.initials: C
authors.lastname: Lienhardt
authors.affiliation: WHO Collaborating centre for TB/HIV and TB elimination, University of Brescia, Brescia, Italy.
authors.forename: Alberto
authors.initials: A
authors.lastname: Matteelli
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D018450:Disease Progression; D005544:Forecasting; D006801:Humans; D059425:Interferon-gamma Release Tests; D055985:Latent Tuberculosis / Q000175:diagnosis* / Q000517:prevention & control* / Q000635:transmission; D008403:Mass Screening / Q000191:economics; D009169:Mycobacterium tuberculosis; D011237:Predictive Value of Tests; D012307:Risk Factors; D014374:Tuberculin Test
chemical_list: D000995:Antitubercular Agents; D015415:Biomarkers